CAV1 and glioblastoma: However, the transcytosis markers caveolin-1 (Cav-1) and PLVAP were robustly detected in IgG-treated GBM vessels, although their levels were substantially decreased by 4E2 or DC101 treatment (Fig. 6c, d, g, h).